CA
TDACU icon

Crossingbridge Advisors’s Translational Development Acquisition Corp Units TDACU Stock Holding History

Crossingbridge Advisors’s Portfolio TDACU Stock Details TDACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-600,000
Closed -$6.01M – 107
2024
Q4 		$6.01M Buy
+600,000
New +$6.01M 1.97% 9

Other funds holding TDACU

Magnetar Financial
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
Wolverine Asset Management
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Picton Mahoney Asset Management
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 51.46% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Crossingbridge Advisors's TDACU Position: Q1 2025 in Review

Crossingbridge Advisors sold out of Translational Development Acquisition Corp Units (TDACU) in Q1 2025, closing a stake of 600,000 shares — an estimated $6.01M sold.

Crossingbridge Advisors first reported a position in TDACU in Q4 2024 and held it in 1 quarter. The position peaked at $6.01M in Q4 2024. 21 funds tracked by Wall St. Rank hold TDACU as of Q1 2025.

  • Crossingbridge Advisors reported no remaining Translational Development Acquisition Corp Units position as of Q1 2025 after selling out during the quarter.
  • Crossingbridge Advisors sold 600,000 Translational Development Acquisition Corp Units shares in Q1 2025, an estimated $6.01M.
  • Crossingbridge Advisors first reported a position in Translational Development Acquisition Corp Units in Q4 2024 and held it in 1 quarter.
  • Crossingbridge Advisors's Translational Development Acquisition Corp Units position peaked at $6.01M in Q4 2024.
  • 21 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Units as of Q1 2025.

Based on Crossingbridge Advisors's 13F filing for Q1 2025, filed 14 May 2025.